Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of tissue-based genomic profiling on clinical decision making in the management of patients with metastatic breast cancer at academic centers.

Breast cancer research and treatment - 1 Nov 2017

Santa-Maria Cesar A, Kruse Megan, Raska Paola, Weiss Mia, Swoboda April, Mutonga Martin B, Abraham Jame, Jain Sarika, Nanda Rita, Montero Alberto J

Abstract excerpt

BACKGROUND: Genomic profiling can identify targetable mutations; however, the impact of tissue-based genomic profiling on clinical decision making for patients with metastatic breast cancer has not been well characterized. METHODS: Patients with stage IV breast cancer who had undergone genomic profiling between 7/2013 and 3/2015 were identified at three academic cancer centers. Genomic analysis was determined to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Academic Medical Centers
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biopsy

Share to Breast Neoplasms

Share to Clinical Decision-Making

Share to Disease Management

Share to Genomics

Share to Neoplasm Staging

Source

Identifiers

PMID: 28752189
DOI: 10.1007/s10549-017-4415-1

Genes

GATA3
MYC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of tissue-based genomic profiling on clinical decision making in the management of patients with metastatic breast cancer at academic centers.PMID 28752189Read ↗

Retrospective review of genomic testing in breast cancer: Does it improve outcome?Semantic proximity Read ↗

Rate of change in investigational treatment options: An analysis of reports from a large precision oncology decision support effort.Semantic proximity Read ↗

Assessment of a cancer genomic profile test for patients with metastatic breast cancer.Semantic proximity Read ↗

Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer.Semantic proximity Read ↗

Initial assessment of a cancer genomic profile test for patients with metastatic breast cancer: a retrospective studySemantic proximity Read ↗

Tumor Tissue- versus Plasma-based Genotyping for Selection of Matched Therapy and Impact on Clinical Outcomes in Patients with Metastatic Breast Cancer.Semantic proximity Read ↗

Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational study.Semantic proximity Read ↗

Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery.Semantic proximity Read ↗

Genomic, Transcriptomic, and Proteomic Profiling of Metastatic Breast Cancer.Semantic proximity Read ↗

Unique molecular signatures as a hallmark of patients with metastatic breast cancer: Implications for current treatment paradigmsSemantic proximity Read ↗

Implementation of a Molecular Tumor Registry to Support the Adoption of Precision Oncology Within an Academic Medical Center: The Duke University ExperienceSemantic proximity Read ↗

Clinical implications of prospective genomic profiling of metastatic breast cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.